Think About Adding Resveratrol To Your Diet
We need to think about incorporating more resveratrol into our diets and supplement taking.
If Big Pharma is coming close to purportedly developing a drug to combat aging and help people live to 150 years old using a synthetic form of resveratrol, then don’t you think we need to do our our own research?
You may say well I’ll just wait until they develop the drug. But is that wise? Assuming that their synthetic form has no problems, why pay their high drug prices and be dependent on them? Moreover, don’t you think it would be better to take natural supplements rather than synthetic ones? After all synthetic drugs carry with them additional side effects, i.e., look at the issues surrounding Premarin. (This is one of many synthetic drugs.)
I have no interest in living until I am 150 years old. However, I would like to reduce my inflammation and other chronic conditions. I don’t want to battle a life threatening illness for years (especially after my 6 year battle with serious life threatening and serious co-morbidity situations. I just want to be able to live an active, relatively pain free lifestyle and enter eternity during sleep. What about you? –No Name Attorney
New drug being developed using compound found in red wine ‘could help humans live until they are 150’
- Drugs are synthetic versions of resveratrol, found in red wine
- Research shows drugs which could prevent cancer and diabetes now viable
- Medication can be taken topically or orally
- No drugs yet developed to target aging skin
PUBLISHED:15:48 EST, 10 March 2013| UPDATED:16:40 EST, 10 March 2013
Breakthrough: The new anti-aging drugs are synthetic versions of resveratrol which is found in red wine
Drugs that could combat ageing and help people to live to 150-years-old may be available within five years, following landmark research.
The new drugs are synthetic versions of resveratrol which is found in red wine and is believed to have an anti-ageing effect as it boosts activity of a protein called SIRT1.
Pharmaceutical giant GlaxoSmithKline has been testing the medications on patients suffering with medical conditions including cancer, diabetes and heart disease.
The work proves that a single anti-ageing enzyme in the body can be targeted, with the potential to prevent age-related diseases and extend lifespans.
As each of the 117 drugs tested work on the single enzyme through a common mechanism is means that a whole new class of anti-ageing drugs is now viable, which could ultimately prevent cancer, Alzheimer’s disease and type 2 diabetes.
Genetics professor David Sinclair, based at Harvard University, said: ‘Ultimately, these drugs would treat one disease, but unlike drugs of today, they would prevent 20 others.
‘In effect, they would slow ageing.’
The target enzyme, SIRT1, is switched on naturally by calorie restriction and exercise, but it can also be enhanced through activators.
The most common naturally-occurring activator is resveratrol, which is found in small quantities in red wine, but synthetic activators with much stronger activity are already being developed.
Although research surrounding resveratrol has been going on for a decade, until now the basic science had been contested.